07/03/2025 5:39 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/30/2025 5:14 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025 1:03 PM | ALTERITY THERAPEUTICS LTD (Subject) Alterity Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SCHEDULE 13G/A | |
05/05/2025 5:17 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2025 8:59 AM | ALTERITY THERAPEUTICS LTD (Subject) Alterity Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SCHEDULE 13G | |
04/30/2025 7:05 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for ATHE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
04/29/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2025 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2025 8:47 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/07/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/07/2025 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/07/2025 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025 7:31 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 5:13 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2025 6:32 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2025 5:50 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 6:59 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 6:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 5:08 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2025 5:56 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 7:13 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 6:59 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025 6:25 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025 6:17 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2025 5:33 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025 5:33 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad) This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto.
Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave. Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin |
01/24/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025 5:35 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025 7:05 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/31/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2024 6:35 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 5:58 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 6:10 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 6:14 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/19/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 5:27 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024 7:00 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024 7:48 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024 8:15 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2024 5:26 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 5:20 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:30 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:32 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:33 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:40 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
09/23/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 5:03 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024 5:07 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 6:06 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2024 5:23 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/24/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2024 5:31 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2024 5:22 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024 5:51 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |